Semaglutide is a medication we offer for the management of type 2 diabetes and chronic weight management, but it may not be appropriate for everyone
There are a few different kinds, but the group getting the most attention right now is called GLP 1 medications
The fix: hold the syringe with the needle pointing up
Bottom line: a rising BMR is a sign my bodys still running strong, even with a reduced appetite
These GLP-1 lawsuits claim that drug manufacturers failed to adequately warn consumers and healthcare providers about the heightened risk of severe gastrointestinal injuries, stomach paralysis, permanent vision loss, and other serious health complications
State Medicaid programs and manufacturers were requested to submit their intentions to participate by January 8, 2026, and the model is expected to begin in May 2026